Autologous bone marrow-derived cell transplantation in decompensated alcoholic liver disease: what is the impact on liver histology and gene expression patterns?

Table 1 Patient baseline inclusion characteristics according to treatment allocation

Variable	Control patients (n = 30)	SCT patients (n = 28)	p value
Age (years)	57 (37–69)	54 (35–67)	0.15
Gender (M/F)	19/11	14/14	0.31
HVPG (mmHg)	19.9 ± 2.4	19.1 ± 2.8	0.28
MELD score	19.1 ± 4.0	19.0 ± 3.8	0.86
Cirrhosis (%)	100	100	0.99
ASH (n, %)	25 (83.3%)	22 (78.6%)	0.64
Corticosteroid treatment (n, %)	22 (73.3%)	16 (57.1%)	0.59

ASH alcoholic steatohepatitis (full histological definition), F female, HVPG hepatic venous pressure gradient, M male, MELD model for end stage liver disease, SCT stem cell therapy

ISSN: 1757-6512